COMMUNIQUÉS West-GlobeNewswire

-
CROSSJECT : Information relative au nombre total de droits de vote et d'actions composant le capital social
14/08/2019 -
Avricore Health Closes $340K First Tranche of Placement
14/08/2019 -
Cubii Takes No. 180 on Inc. 500 List of Fastest-Growing Companies
14/08/2019 -
Genmab Announces Financial Results for the First Half of 2019 and Updates 2019 Financial Guidance
14/08/2019 -
NovuHealth Captures Another Prestigious Growth Award
14/08/2019 -
SAVING YEMEN: FOUR U.S. NGOS TEAM UP TO LAUNCH HIGHLY COORDINATED RESPONSE
14/08/2019 -
North Bud Farms Completes Construction of its Phase One Cultivation Facility and Establishes U.S. Based Subsidiary, Bonfire Brands USA
14/08/2019 -
Movement Industries Corp. (OTC: VSHC) Announces Signing of Binding Letter of Intent for the Acquisition of Predominant Pumps
14/08/2019 -
ChromaDex Announces $7 Million Private Placement of Common Stock
14/08/2019 -
ReNetX Bio Announces Initiation of Patient Dosing in the First Phase 1 Clinical Trial of Fusion Protein AXER-204
14/08/2019 -
Dave Kenney to Speak at Allied Academies 3rd International Conference on Addiction Research and Therapy
14/08/2019 -
Zosano Pharma Files IND to Initiate a Phase 2/3 Clinical Study in Cluster Headache
14/08/2019 -
Adamis Pharmaceuticals Strengthens Patent Portfolio for its U.S. Compounding Subsidiary
14/08/2019 -
Orasure Technologies Appoints James a. Datin to Its Board of Directors
14/08/2019 -
ViroGates appoints Mark Christian Hvidberg da Silva as its new CFO
14/08/2019 -
Resverlogix to Present at the European Society of Cardiology’s ESC Congress 2019
14/08/2019 -
Sharps Compliance Announces Fourth Quarter Fiscal 2019 Conference Call and Webcast
14/08/2019 -
Hepion Pharmaceuticals Announces Dosing of First HBV Patient in 28-Day Study of CRV431
14/08/2019 -
Ultragenyx Announces Partnership with GeneTx to Advance Treatment for Angelman Syndrome
14/08/2019
Pages